← All stocks

Theriva Biologics, Inc.

TOVX Net buying
CIK 0000894158 #5232 in the set updated 21 Sep 2026
Bought (120 mo)
$205.35K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$98.84K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$98.84K
6 of 6 sales
Net
+$106.52K
+$106.52K against sales at will

By person

4 insiders · 16 transactions
0.2×

Steven Shallcross holds only 0.2 times base salary in stock. $173.28K of shares against $667.54K in salary for 2025.

Salary from the company's own proxy. The shares are what Steven Shallcross last reported holding, valued at $0.69, the price Common Stock was last bought or sold at on the open market here, on 7 Jun 2023.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SHALLCROSS STEVEN A
CEO and CFO
$205.35K (9)
+$205.35K
250,000
$173.28K
KIRK RANDAL J
10% owner
$98.84K (6)
−$98.84K
227,674
$157.80K
−39.8%
Tarriff Scott
Former Director
300,000
$207.93K
Kraws Jeffrey J
Director
228,773
$158.56K

No percentages here. This company's share count has moved by a factor of 16.5 over the window, from 2,782,449 to 45,892,668 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SHALLCROSS STEVEN A
7 Jun 2023
CEO and CFO
Buy
14,000
$0.69
$9.70K
SHALLCROSS STEVEN A
6 Jun 2023
CEO and CFO
Buy
26,000
$0.63
$16.45K
SHALLCROSS STEVEN A
10 Feb 2023
CEO and CFO
Buy
25,000
$1.04
$26.08K
SHALLCROSS STEVEN A
2 Feb 2023
CEO and CFO
Buy
25,000
$0.94
$23.51K
SHALLCROSS STEVEN A
25 Jan 2023
CEO and CFO
Buy
25,000
$0.87
$21.83K
SHALLCROSS STEVEN A
20 Jan 2023
CEO and CFO
Buy
25,000
$0.75
$18.71K
SHALLCROSS STEVEN A
29 Dec 2022
CEO and CFO
Buy
100,000
$0.44
$43.70K
SHALLCROSS STEVEN A
10 May 2021
CEO and CFO
Buy
50,000
$0.49
$24.60K
SHALLCROSS STEVEN A
23 Aug 2019
CEO and CFO
Buy
50,000
$0.42
$20.79K
KIRK RANDAL J
3 Apr 2019
10% owner
Sell indirect
69,161
$0.65
$44.95K
KIRK RANDAL J
3 Apr 2019
10% owner
Sell indirect
26,080
$0.65
$16.95K
KIRK RANDAL J
2 Apr 2019
10% owner
Sell indirect
9,909
$0.66
$6.54K
KIRK RANDAL J
2 Apr 2019
10% owner
Sell indirect
3,737
$0.66
$2.47K
KIRK RANDAL J
1 Apr 2019
10% owner
Sell indirect
30,265
$0.67
$20.28K
KIRK RANDAL J
1 Apr 2019
10% owner
Sell indirect
11,413
$0.67
$7.65K
Kraws Jeffrey J
14 Mar 2017
Director
Exercised, kept
228,773
$0.09
$20.59K

What was left out

Form 4 filings counted 57
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 528,773
Sales filed before the plan box existed 6
History held since 18 Nov 2016